Physician profile
Michael Paul Asher
NPI 1437657723
$405.36
in general payments reported to CMS, 2019-2025
11 companies · $308 in 2025
The $308 reported for 2025 was more than what 94% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.34 · 2023: $51.53 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.56 | 2025 | Xifaxan |
| Janssen Biotech, INC. | $75.39 | 2025 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $59.84 | 2025 | Entyvio |
| Edwards Lifesciences Corporation | $51.53 | 2023 | Swan-Ganz |
| Lilly USA, LLC | $31.17 | 2025 | Omvoh |
| Regeneron Healthcare Solutions, INC. | $26.07 | 2025 | Dupixent |
| Ge Healthcare | $19.81 | 2021 | |
| Aimmune Therapeutics, INC. | $16.03 | 2025 | Zenpep |
| Novo Nordisk INC | $15.43 | 2025 | Wegovy |
| Chiesi USA, INC. | $14.19 | 2021 | |
| Merck Sharp & Dohme LLC | $11.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Asher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.